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Background:  Idiopathic giant cell myocarditis (IGCM) is a rare but fulminant process leading to rapid heart failure. Prior case series have 
suggested a relationship with autoimmune diseases, but an association with type I diabetes mellitus (DM) has not been described.
case:  A 56 year old woman with a history of type I DM, atrial fibrillation (AF) and hypothyroidism presented with a two day history 
of fevers, myalgias, chest heaviness, and AF with rapid ventricular response (RVR). On exam, she was hypotensive, tachycardic, 
and hypovolemic. Initial laboratory analysis showed hyperglycemia, anion gap metabolic acidosis, and mild troponinemia. Her 
electrocardiogram (ECG) exhibited low voltages, similar to her prior ECGs, but with new diffuse non-specific ST changes.
decision Making:  Her initial presentation appeared consistent with diabetic ketoacidosis triggered by a viral syndrome. Despite glycemic 
and rhythm control with volume resuscitation, her cardiac biomarkers continued to rise, with troponin I peaking at 11.3 ng/mL. An admission 
echocardiogram was normal; however, repeat evaluation revealed declining left ventricular function, correlating clinically with progressive 
volume overload. Coronary angiography was negative, and right heart catheterization confirmed elevated intracardiac pressures with a 
mixed venous oxygen saturation of 45%. Intensive diuresis and hemodynamic optimization resulted in clinical improvement with restoration 
of sinus rhythm, but 36 hours later she redeveloped signs of cardiogenic shock and recurrent AF with RVR. Due to a high index of 
suspicion for fulminant myocarditis, the patient underwent emergent endomyocardial biopsy followed by empiric steroid therapy. The biopsy 
showed multi-nucleated giant cells consistent with IGCM. Fourteen days after initial presentation, she underwent successful orthotopic 
heart transplant.
conclusion:  Our patient’s presentation of initial stabilization preceding fulminant cardiogenic shock differs from the usual course of clinical 
deterioration in IGCM. The history of an antecedent viral illness occurring in the setting of an autoimmune phenotype may provide clues on 
pathogenesis and prognosis.
